Novel molecular imaging drug offers better detection of prostate cancer

(Society of Nuclear Medicine) A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone. The research, published in the November issue of the Journal of Nuclear Medicine, compares the biodistribution and tumor uptake kinetics of two Tc-99m labeled ligands, MIP-1404 and MIP-1405, used with SPECT and planar imaging.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news